Pilz G, Fraunberger P, Appel R, Kreuzer E, Werdan K, Walli A, Seidel D
Department of Medicine I, Grosshadern University Hospital, University of Munich, Germany.
Crit Care Med. 1996 Apr;24(4):596-600. doi: 10.1097/00003246-199604000-00008.
To investigate the prognostic value of increased serum concentrations of soluble tumor necrosis factor (TNF) receptors in patients at high risk for sepsis.
Prospective study.
Cardiac surgical intensive care unit in a University Hospital.
Those 27 of 870 consecutive postcardiac surgical patients who met a previously validated high-risk criterion for imminent sepsis (Acute Physiology and Chronic Health Evaluation II [APACHE II] score of > or = 24 on the first postoperative day [day 1]). In this population, systemic inflammatory response syndrome was present in 96% of the patients and the in-hospital mortality rate was 30%. In addition, ten postcardiac surgical patients with an uncomplicated course (mortality rate 0%) were studied for comparison.
Blood sampling for measurements of serum concentrations of TNF and soluble TNF receptors 55 kilodalton (TNF receptor-p55) and 75 kilodalton (TNF receptor-p75) on days 1, 2, 3, and 5.
Compared with the ten patients with an uncomplicated course (group A), the high-risk patients had significantly higher baseline (day 1) serum concentrations of soluble TNF receptor-p55 (9.2 vs. 4.2 ng/mL) and soluble TNF receptor-p75 (9.2 vs. 5.5 ng/mL). These high-risk patients could be further differentiated into two subgroups: one (B) with a prompt decrease in APACHE II score and a good prognosis (mortality rate 0%) and another (C) with a persisting high risk of sepsis and mortality rate (40%, p < .05). Although baseline APACHE II score was similar in both high-risk subgroups, soluble TNF receptor-p55 concentrations were significantly higher in subgroup C compared with subgroup B already at baseline (10.7 vs. 4.7 ng/mL). The receiver operating characteristic curve for subgroup classification by soluble TNF receptor-p55 was in a discriminating position with an area (0.773 +/- 0.096), confirming soluble TNF receptor-p55 as a predictor of mortality. TNF and soluble TNF receptor-p75 concentrations were less predictive at baseline.
This study suggest that increased soluble TNF receptor-p55 concentrations in the serum of postcardiac surgical patients allow earlier prognostication of subsequent hospital course than APACHE II scores alone. This study further suggests that the combination of physiologic scores and cytokine receptor measurements could improve the predictive power of early postoperative risk stratification.
探讨血清可溶性肿瘤坏死因子(TNF)受体浓度升高在脓毒症高危患者中的预后价值。
前瞻性研究。
大学医院的心脏外科重症监护病房。
870例连续心脏手术后患者中,符合先前验证的即将发生脓毒症高危标准(术后第1天急性生理与慢性健康状况评分II [APACHE II]≥24分)的27例患者。在该人群中,96%的患者存在全身炎症反应综合征,住院死亡率为30%。此外,研究了10例心脏手术后病程平稳(死亡率0%)的患者作为对照。
在第1、2、3和5天采集血样,检测血清TNF、可溶性TNF受体55千道尔顿(TNF受体-p55)和75千道尔顿(TNF受体-p75)的浓度。
与10例病程平稳的患者(A组)相比,高危患者基线(第1天)血清可溶性TNF受体-p55(9.2对4.2 ng/mL)和可溶性TNF受体-p75(9.2对5.5 ng/mL)浓度显著更高。这些高危患者可进一步分为两个亚组:一个亚组(B组)APACHE II评分迅速下降且预后良好(死亡率0%),另一个亚组(C组)脓毒症和死亡率持续高危(40%,p<0.05)。尽管两个高危亚组的基线APACHE II评分相似,但C组可溶性TNF受体-p55浓度在基线时就显著高于B组(10.7对4.7 ng/mL)。可溶性TNF受体-p55用于亚组分类的受试者工作特征曲线处于有鉴别力的位置,曲线下面积为(0.773±0.096),证实可溶性TNF受体-p55可作为死亡率预测指标。TNF和可溶性TNF受体-p75浓度在基线时预测价值较小。
本研究表明,心脏手术后患者血清中可溶性TNF受体-p55浓度升高比单独的APACHE II评分能更早地对后续住院病程进行预后评估。本研究还表明,生理评分与细胞因子受体测量相结合可提高术后早期风险分层的预测能力。